Rehman et al evaluated dyspneic patients in the Emergency Department using C-reactive protein (CRP) and pro-Brain natriuretic peptide (NT-proBNP). They identified patients at risk for increased 1 year mortality. The authors are from Massachusetts General Hospital and Northwestern University.
